Asston Pharmaceuticals Ltd Share Price

₹84.21 -1.85 (-2.15%) BSE
as updated on 24-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:84.00
  • Day's High:86.10

  • 52 Week Low75.21
  • 52 Week High126.00

Asston Pharmaceuticals Ltd's key Fundamentals

Market Cap ₹73 Cr.
P/E Ratio 16.9
TTM EPS 5.1
P/B Ratio 5.65
ROE 52.03
Debt to Equity 0.68
Face Value 10
BVPS 15.2
3 Year Sales Growth 37.65%

Asston Pharmaceuticals Ltd's Share Price Returns

1 Day -2.15%
1 Week -1.20%
1 Month 0.00%
3 Months -15.80%
6 Months 0.00%
1 Years 0.00%
3 Years 0.00%
5 Years 0.00%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Asston Pharmaceuticals Ltd Shareholding Pattern

Promoters

(50.66%)

Institutions

(6.04%)

Non-Institutions

(43.30%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Asston Pharmaceuticals Ltd

Asston Pharmaceuticals Limited was originally incorporated as ‘Asston Pharmaceuticals Private Limited’, a private limited company under Companies Act, 2013, pursuant to a certificate of incorporation dated April 16, 2019 issued by Registrar of Companies, Mumbai, Maharashtra. Thereafter, the company was converted into a public limited company and the name of the company was changed from ‘Asston Pharmaceuticals Private Limited’ to ‘Asston Pharmaceuticals Limited’ vide fresh certificate of incorporation dated August 29, 2024 issued by the Registrar of Companies, Mumbai, Maharashtra.

The company is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African markets. The company operates under brand ‘Asston’. The company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion) and Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, the company also manufactures various pharmaceutical products for different marketers on loan license or on contract manufacturing basis. Its business is primarily conducted on a principle-to-principle basis with various marketers.

It caters to multiple corporate clients on loan licence and/or contract manufacturing basis. The company basically gives contract for manufacturing the products to WHO-GMP certified contract manufacturers and FDA-accredited laboratories, ensuring adherence to industry standards from production to export. From manufacturing to exports and distributions, the company takes responsibility and oversees each phase of the supply chain.

Business area of the company

The company is engaged in the business of manufacturing pharmaceutical products.

Products of the company

Tablets

  • Albendazole USP 400 mg
  • KJFEN-50
  • Mebenex
  • Recomax
  • Ovcyst
  • Max- Relief
  • B-complex tablets

Capsules

  • Diclofenac 100 mg
  • Solocam
  • Omeprazole Capsules
  • All Cold
  • Medart Forte
  • Ampicloxa 500
  • Singatone Forte

Oral Suspension and Syrup and Creams

  • Ibuprofen, paracetamol
  • Ferrovit Syrup
  • Asstofer
  • Gripe Water
  • Folirex Forte Syrup
  • Clotrimazole Cream USP 1 % w/v
  • B-complex syrup

History and milestones

  • 2019: Incorporation of the Company viz. ‘Asston Pharmaceuticals Private Limited’ under the guidance and leadership of Dr. Ashish Narayan Sakalkar and Mrs. Saili Jayaram More.
  • 2019: The company obtained Trade and Export Licenses for 3 major west African Countries namely Sierra Leone, Ghana and Liberia.
  • 2020: The company obtained registered trademarks in both India and abroad for multiple products, enhancing its images as a pharmaceutical brand in late 2020.
  • 2021: The company crossed Rs 10 crore turnover mark in 2021, less than two years since inception.
  • 2022: Established its Manufacturing unit in Mumbai which is one of the company’s achievement making it an independent and reliable supplier.
  • 2023: The company has successfully ventured into other African countries and is expected to receive registration from Asian markets like Cambodia and Vietnam.
  • 2024: Conversion of the company from Private Limited to Public Limited Company.

Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 84.00
  • Day's High: 86.10

  • 52 Week Low75.21
  • 52 Week High126.00

Asston Pharmaceuticals Ltd's key Fundamentals

Market Cap ₹73 Cr.
P/E Ratio 16.9
TTM EPS 5.1
P/B Ratio 5.65
ROE 52.03
Debt to Equity 0.68
Face Value 10
BVPS 15.2
3 Year Sales Growth 37.65%

Asston Pharmaceuticals Ltd's Share Price Returns

1 Day -2.15%
1 Week -1.20%
1 Month 0.00%
3 Months -15.80%
6 Months 0.00%
1 Years 0.00%
3 Years 0.00%
5 Years 0.00%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×